Ehx G, Ritacco C, Baron F
Biomark Res. 2024; 12(1):139.
PMID: 39543777
PMC: 11566168.
DOI: 10.1186/s40364-024-00684-9.
Tanweer S, Sharma T, Grover A, Agarwal M, Grover S
ACS Omega. 2024; 9(31):33743-33750.
PMID: 39130601
PMC: 11308015.
DOI: 10.1021/acsomega.4c02919.
Elsayed A, Pellegrino C, Pluss L, Peissert F, Benz R, Ulrich F
MAbs. 2023; 15(1):2220839.
PMID: 37288872
PMC: 10251795.
DOI: 10.1080/19420862.2023.2220839.
Tserunyan V, Finley S
Semin Cancer Biol. 2023; 94:34-49.
PMID: 37263529
PMC: 10529846.
DOI: 10.1016/j.semcancer.2023.05.009.
Verlaat L, Riesner K, Kalupa M, Jung B, Mertlitz S, Schwarz C
Front Immunol. 2023; 13:1079921.
PMID: 36761159
PMC: 9902926.
DOI: 10.3389/fimmu.2022.1079921.
GPR174 signals via Gs to control a CD86-containing gene expression program in B cells.
Wolf E, Howard Z, Duan L, Tam H, Xu Y, Cyster J
Proc Natl Acad Sci U S A. 2022; 119(23):e2201794119.
PMID: 35639700
PMC: 9191659.
DOI: 10.1073/pnas.2201794119.
Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients.
Zarzuelo-Romero M, Perez-Ramirez C, Cura Y, Carrasco-Campos M, Marangoni-Iglecias L, Ramirez-Tortosa M
J Pers Med. 2021; 11(10).
PMID: 34683173
PMC: 8540092.
DOI: 10.3390/jpm11101032.
GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models.
Hess N, Brown M, Capitini C
Front Immunol. 2021; 12:723544.
PMID: 34394131
PMC: 8358790.
DOI: 10.3389/fimmu.2021.723544.
MHC Class I on murine hematopoietic APC selects Type A IEL precursors in the thymus.
Lee S, Georgiev H, Breed E, Ruscher R, Hogquist K
Eur J Immunol. 2021; 51(5):1080-1088.
PMID: 33521937
PMC: 9846822.
DOI: 10.1002/eji.202048996.
CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4.
Halliday N, Williams C, Kennedy A, Waters E, Pesenacker A, Soskic B
Front Immunol. 2020; 11:600000.
PMID: 33363541
PMC: 7753196.
DOI: 10.3389/fimmu.2020.600000.
Bacteria Expressing -Specific Rv1954A Induce Macrophage Activation and Modulate the Immune Response.
Arora S, Naqvi N, Alam A, Ahmad J, Alsati B, Sheikh J
Front Cell Infect Microbiol. 2020; 10:564565.
PMID: 33163415
PMC: 7583720.
DOI: 10.3389/fcimb.2020.564565.
Immunodominant Protein Rv1507A Elicits Th1 Response and Modulates Host Macrophage Effector Functions.
Arora S, Alam A, Naqvi N, Ahmad J, Sheikh J, Rahman S
Front Immunol. 2020; 11:1199.
PMID: 32793184
PMC: 7385400.
DOI: 10.3389/fimmu.2020.01199.
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).
Cossarizza A, Chang H, Radbruch A, Acs A, Adam D, Adam-Klages S
Eur J Immunol. 2019; 49(10):1457-1973.
PMID: 31633216
PMC: 7350392.
DOI: 10.1002/eji.201970107.
Local Delivery of , , and mRNA Kindles Global Anticancer Immunity.
Haabeth O, Blake T, McKinlay C, Tveita A, Sallets A, Waymouth R
Cancer Res. 2019; 79(7):1624-1634.
PMID: 30692215
PMC: 6445668.
DOI: 10.1158/0008-5472.CAN-18-2867.
Impairs the Function of and Kills Human Dendritic Cells via the LukAB Toxin.
Berends E, Zheng X, Zwack E, Menager M, Cammer M, Shopsin B
mBio. 2019; 10(1).
PMID: 30602580
PMC: 6315100.
DOI: 10.1128/mBio.01918-18.
Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice.
Ehx G, Somja J, Warnatz H, Ritacco C, Hannon M, Delens L
Front Immunol. 2018; 9:1943.
PMID: 30214443
PMC: 6125392.
DOI: 10.3389/fimmu.2018.01943.
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy.
Du X, Tang F, Liu M, Su J, Zhang Y, Wu W
Cell Res. 2018; 28(4):416-432.
PMID: 29472691
PMC: 5939050.
DOI: 10.1038/s41422-018-0011-0.
CD28-mediated T cell response is upregulated by exogenous application of autologous Hsp70-peptide complex in a tumor-bearing host.
Kumar S, Kumar Gautam P, Tomar M, Acharya A
Immunol Res. 2015; 64(1):313-23.
PMID: 26639355
DOI: 10.1007/s12026-015-8752-z.
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.
Paterson A, Lovitch S, Sage P, Juneja V, Lee Y, Trombley J
J Exp Med. 2015; 212(10):1603-21.
PMID: 26371185
PMC: 4577848.
DOI: 10.1084/jem.20141030.
Lack of galectin-1 or galectin-3 alters B cell deletion and anergy in an autoantibody transgene model.
Clark A, Weston M, Foster M
Glycobiology. 2013; 23(7):893-903.
PMID: 23550149
PMC: 3671777.
DOI: 10.1093/glycob/cwt026.